Cargando…

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

INTRODUCTION: Survival and best supportive care (BSC) costs for patients with metastatic renal cell carcinoma (mRCC), after stopping therapy, are poorly characterized yet an important aspect of patient care. This study examined survival and costs associated with BSC after one or two lines of therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henk, Henry J, Chen, Connie, Benedict, Agnes, Sullivan, Jane, Teitelbaum, April
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711649/ https://www.ncbi.nlm.nih.gov/pubmed/23874112 http://dx.doi.org/10.2147/CEOR.S45756

Ejemplares similares

A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan
por: Su, Po‐Jung, et al.
Publicado: (2023)

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study
por: Lal, Lincy S., et al.
Publicado: (2021)

Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims
por: Freedland, Stephen J., et al.
Publicado: (2023)

Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
por: Xie, Qian, et al.
Publicado: (2022)

The Best Methods for Newly Claimed Areas
Publicado: (1921)

Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
por: Xie, Qian, et al.
Publicado: (2022)

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
por: Pal, Sumanta, et al.
Publicado: (2019)

Unemployment claims during COVID-19 and economic support measures in the U.S.
por: Dergiades, Theologos, et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
por: Goswami, Hardik, et al.
Publicado: (2022)

Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
por: Ma, Qiufei, et al.
Publicado: (2018)

Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma
por: Han, Jiaqi, et al.
Publicado: (2023)

Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
por: Goswami, Hardik, et al.
Publicado: (2023)

Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data
por: Marvel, Jessica, et al.
Publicado: (2019)

Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis
por: Song, Xue, et al.
Publicado: (2019)

Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database
por: Hasan Albitar, Hasan Ahmad, et al.
Publicado: (2020)

Incidence, costs and post-operative complications following ankle fracture – A US claims database analysis
por: Vanderkarr, Mari F., et al.
Publicado: (2022)

S107. HEALTHCARE UTILIZATION AND COST IN SCHIZOPHRENIA AND BIPOLAR DISORDER: REAL-WORLD EVIDENCE FROM US CLAIMS DATABASES
por: Greene, Mallik, et al.
Publicado: (2018)

Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database
por: Walsh, Jessica A., et al.
Publicado: (2018)

Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
por: Perera, Sue, et al.
Publicado: (2018)

Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims
por: Sacks, Naomi C, et al.
Publicado: (2021)

The Claiming Costs Scale: A new instrument for measuring the costs potential beneficiaries face when claiming social benefits
por: Janssens, Julie, et al.
Publicado: (2021)

Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study
por: Kreis, Kristine, et al.
Publicado: (2020)

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
por: Freedland, Stephen J., et al.
Publicado: (2021)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
por: Schroeder, Krista M, et al.
Publicado: (2019)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Persistence and Compliance with Pazopanib in Patients with Advanced Renal Cell Carcinoma Within a U.S. Administrative Claims Database
por: Hackshaw, Michelle D., et al.
Publicado: (2014)

Healthcare costs of patients on different renal replacement modalities – Analysis of Dutch health insurance claims data
por: Mohnen, Sigrid M., et al.
Publicado: (2019)

Cost, Severity and Prevalence of Agricultural-Related Injury Workers’ Compensation Claims in Farming Operations from 14 U.S. States
por: Baidwan, Navneet Kaur, et al.
Publicado: (2021)

Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data
por: Choong, Casey K., et al.
Publicado: (2018)

Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Study
por: Srisawat, Nattachai, et al.
Publicado: (2010)

Probiotics and prebiotics: health claim substantiation
por: Salminen, Seppo, et al.
Publicado: (2012)

Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data
por: Chen, Yi, et al.
Publicado: (2019)

Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis
por: Coleman, Craig I., et al.
Publicado: (2019)

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer
por: Kim, Tae Won, et al.
Publicado: (2016)

U.S. officials dismiss a Big Isle man's claims
Publicado: (2008)

Risk factors and healthcare costs associated with long bone fracture non-union: a retrospective US claims database analysis
por: Vanderkarr, Mari F., et al.
Publicado: (2023)

Interpreting overall survival results when progression-free survival benefits exist in today’s oncology landscape: a metastatic renal cell carcinoma case study
por: Tang, Yiyun, et al.
Publicado: (2014)

The New Weibull handbook: reliability and statistical analysis for predicting life, safety, supportability, risk, cost and warranty claims
por: Abernethy, Robert B
Publicado: (2004)

Cost of Hospital Treatment Claimed from a Doctor
Publicado: (1914)

Cannot write session to /tmp/vufind_sessions/sess_7q44camvuuc8gbjhg4gpn35rg1